Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) is not a blood thinner. It does not thin your blood, reduce clotting, or act on platelets or coagulation pathways in any way. It is a dual GIP and GLP-1 receptor agonist licensed in the UK for weight management and type 2 diabetes, and its mechanisms are entirely unrelated to blood viscosity or anticoagulation. That said, if you take a prescribed anticoagulant such as warfarin, the question of how Mounjaro interacts with your existing medicines is a real and reasonable one to raise with a prescriber before starting treatment — and one our clinical team takes seriously at every consultation.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Perhaps someone mentioned that Mounjaro affects the blood, or you read something online and couldn't find a clear answer. This is a question our prescribers hear most weeks, sometimes from people already on warfarin or apixaban who want to know whether tirzepatide will interfere with their INR, and sometimes from people who've seen vague warnings about "blood effects" without any explanation of what that actually means.
The short answer is firm: Mounjaro does not thin your blood, and our page covering whether Mounjaro is a blood thinner walks through exactly why that is the case. It belongs to a class of medicines called GIP and GLP-1 receptor agonists, and its actions are focused on appetite regulation, gastric emptying, and blood-sugar control. There is no anticoagulant, antiplatelet, or fibrinolytic component in its mechanism. You can read a straightforward overview of how tirzepatide works on our tirzepatide information page.
Where the nuance lies is in how Mounjaro's effect on gastric emptying can influence the absorption of other oral medicines taken at the same time. Slow gastric emptying means food and medicines linger longer in the stomach before moving to the small intestine, where most absorption happens. For most medicines this effect is modest and clinically unremarkable. For narrow-therapeutic-index drugs (warfarin being the textbook example) even a small change in absorption timing can shift INR readings enough to matter. That is not Mounjaro thinning your blood; it is Mounjaro altering the pharmacokinetics of a medicine that affects your blood's clotting ability. The distinction is important. The NHS tirzepatide medicines page notes this interaction risk and advises discussing all current medicines with your prescriber before starting.
If you are prescribed warfarin, heparin, apixaban, rivaroxaban, or any other anticoagulant, your prescriber needs to know before Mounjaro is initiated. This is not a reason to rule out treatment automatically, it is a reason for careful clinical review. For people on warfarin specifically, the standard practice is closer INR monitoring in the weeks after starting Mounjaro and after each dose increase, because the gastric-emptying effect is most pronounced at initiation and at titration steps. More detail on the practicalities is covered on our page about Mounjaro and blood thinners.
Apixaban and rivaroxaban (the direct oral anticoagulants, or DOACs) have a different absorption profile to warfarin and are generally considered lower risk in this context, but prescriber oversight still applies. If you are uncertain whether a medicine you take counts as a blood thinner, your GP or pharmacist can clarify quickly.
At nume, every person's full medication list is reviewed as part of the consultation, before anything is prescribed. A real clinician reads your answers the same day; no automated system makes that call. If you want to understand what that process looks like, the Mounjaro treatment page sets it out clearly, and our about us page explains the clinical oversight behind the service. If you have existing questions about the cost of treatment, the weight-loss treatments page shows what is included in a single transparent price.
Because Mounjaro is not a blood thinner, starting it does not typically prompt routine coagulation blood tests for people who are not already on anticoagulants. The blood monitoring that does matter tends to be metabolic: HbA1c for anyone with diabetes or prediabetes, kidney function if there are concerns about dehydration from gastrointestinal side effects, and liver function in some clinical contexts. For people on warfarin, as noted above, INR checks are the relevant monitoring tool during initiation.
Some people also wonder whether Mounjaro causes hair thinning, a completely separate concern that sometimes gets conflated with "blood" or "thinning" language. Those are two unrelated processes; if that is your concern, our page on whether Mounjaro thins your hair covers the evidence directly. For a broader look at what blood tests a prescriber might request alongside treatment, see the Mounjaro blood test page.
Mounjaro is a prescription-only medicine and requires clinical assessment before it can be prescribed. The prescriber's job is to weigh your full medical picture (including every medicine you already take) and decide whether treatment is appropriate. If you are ready to have that conversation, you can start your free consultation with our clinical team today.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.